Skip to main content
. Author manuscript; available in PMC: 2019 Jun 7.
Published in final edited form as: Epidemiology. 2017 Nov;28(6):838–846. doi: 10.1097/EDE.0000000000000709

Table 1.

Baseline characteristics of glyburide users and glipizide users from 13 Sentinel data partners.

Covariates Unmatched Matched on propensity score

New Users a Glyburide
(N=198,553)
Glipizide
(N=379,508)
Standardized
difference
Glyburide
(N=173,657)
Glipizide
(N=173,657)
Standardized
difference

Sex, female 101,307 (51.0%) 166,997 (44.0%)  0.141 78,013 (44.9%) 80,048 (46.1%) −0.024
Mean age (SD) 55.0 (13.9) 59.7 (12.7) −0.353 57.9 (12.8) 57.7 (12.5)  0.016
Recorded history of
 Chronic kidney disease 11,640 (5.9%) 42,418 (11.2%) −0.190 11,579 (6.7%) 12,794 (7.4%) −0.027
 Serious Hypoglycemia 4,532 (2.3%) 18,754 (4.9%) −0.143 4,433 (2.6%) 4,657 (2.7%) −0.008
 Insulin 14,903 (7.1%) 34,011 (9.0%) −0.069 13,692 (7.9%) 13,988 (8.1%) −0.006
 Metformin 66,450 (33.5%) 183,560 (48.4%) −0.303 65,680 (37.8%) 67,446 (38.8%) −0.021
 Other antidiabetic drugs 28,462 (14.3%) 55,113 (14.5%)  0.005 28,248 (16.3%) 28,908 (16.6%) −0.010
Combined Charlson/Elixhauser comorbidity score (SD) 0.4 (1.7) 0.7 (2.0) −0.151 0.5 (1.7) 0.6 (1.8) −0.040
Health Service Utilization Intensity
 Number of unique drugs dispensed (SD) 5.3 (4.3) 6.3 (4.6) −0.218 5.6 (4.4) 5.7 (4.5) −0.030
 Number of dispensed prescriptions (SD) 12.6 (13.1) 14.2 (13.5) −0.121 13.6 (13.7) 14.0 (13.9) −0.026
 Number of inpatient hospital encounters (SD) 0.1 (0.5) 0.2 (0.6) −0.094 0.1 (0.5) 0.1 (0.5)  0.000
 Number of non-acute institutional encounters (SD) 0.1 (0.9) 0.1 (1.0)  0.034 0.1 (1.0) 0.1 (1.0)  0.000
 Number of emergency room encounters (SD) 0.3 (0.7) 0.3 (0.8)  0.029 0.3 (0.8) 0.3 (0.8)  0.000
 Number of ambulatory encounters (SD) 6.9 (7.6) 6.3 (7.8)  0.082 6.5 (7.4) 6.8 (8.7) −0.037
 Number of other ambulatory encounters (SD) b 2.0 (3.5) 2.7 (4.4) −0.167 1.7 (3.3) 1.9 (3.8) −0.036

SD – Standard deviation.

a

Please note, one Data Partner removed a small number of users that moved to administrative services-only plans. Information from these users is included in Tables 1 and 2, but removed from subsequent tables.

b

Other ambulatory encounters included telemedicine and email consults, etc.